{
  "api_version": "1",
  "request": {
    "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neonatal+Hearing+Loss",
    "query": {
      "condition": "Neonatal Hearing Loss"
    },
    "page_size": 10
  },
  "pagination": {
    "page": 1,
    "page_size": 10,
    "total_count": 51,
    "total_pages": 6,
    "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neonatal+Hearing+Loss&page=2&page_size=10",
    "previous_page_url": null
  },
  "source": "remote",
  "last_synced_at": "2026-09-18T21:02:39.095Z",
  "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.",
  "notes": [
    "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.",
    "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.",
    "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees."
  ],
  "trials": [
    {
      "nct_id": "NCT00016471",
      "title": "A Genetic Analysis of Usher Syndrome in Ashkenazi Jews",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Usher Syndrome",
        "Retinitis Pigmentosa",
        "Congenital Hearing Impairment"
      ],
      "interventions": [
        {
          "name": "Audiogram",
          "type": "PROCEDURE"
        },
        {
          "name": "Electroretinogram",
          "type": "PROCEDURE"
        }
      ],
      "intervention_types": [
        "PROCEDURE"
      ],
      "sponsor": "National Center for Research Resources (NCRR)",
      "sponsor_class": "NIH",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "0 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "0 Years and older"
      },
      "enrollment_count": null,
      "start_date": "2001-03",
      "completion_date": "2002-02",
      "has_results": false,
      "last_update_posted_date": "2005-06-24",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "New York, New York",
      "locations": [
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00016471"
    },
    {
      "nct_id": "NCT06627179",
      "title": "Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene",
      "overall_status": "ACTIVE_NOT_RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Retinitis Pigmentosa (RP)",
        "Usher Syndrome Type 2",
        "Deaf Blind",
        "Retinal Disease",
        "Eye Diseases, Hereditary",
        "Eye Disorders Congenital",
        "Vision Disorders"
      ],
      "interventions": [
        {
          "name": "Intravitreal Injection of Ultevursen",
          "type": "DRUG"
        },
        {
          "name": "No intervention, will not receive any active study intervention",
          "type": "OTHER"
        }
      ],
      "intervention_types": [
        "DRUG",
        "OTHER"
      ],
      "sponsor": "Laboratoires Thea",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "8 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "8 Years and older"
      },
      "enrollment_count": 81,
      "start_date": "2024-12-11",
      "completion_date": "2028-07",
      "has_results": false,
      "last_update_posted_date": "2026-07-09",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 10,
      "location_summary": "San Francisco, California • Miami, Florida • Atlanta, Georgia + 7 more",
      "locations": [
        {
          "city": "San Francisco",
          "state": "California"
        },
        {
          "city": "Miami",
          "state": "Florida"
        },
        {
          "city": "Atlanta",
          "state": "Georgia"
        },
        {
          "city": "Boston",
          "state": "Massachusetts"
        },
        {
          "city": "Ann Arbor",
          "state": "Michigan"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06627179"
    },
    {
      "nct_id": "NCT02829268",
      "title": "A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE1",
        "PHASE2"
      ],
      "conditions": [
        "Wolfram Syndrome",
        "Diabetes Mellitus",
        "Optic Nerve Atrophy",
        "Ataxia"
      ],
      "interventions": [
        {
          "name": "dantrolene sodium",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Washington University School of Medicine",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "5 Years",
        "maximum_age": "60 Years",
        "sex": "ALL",
        "summary": "5 Years to 60 Years"
      },
      "enrollment_count": 21,
      "start_date": "2017-01",
      "completion_date": "2023-02",
      "has_results": true,
      "last_update_posted_date": "2024-03-13",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "St Louis, Missouri",
      "locations": [
        {
          "city": "St Louis",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02829268"
    },
    {
      "nct_id": "NCT00004345",
      "title": "Study of Dietary N-3 Fatty Acids in Patients With Retinitis Pigmentosa and Usher Syndrome",
      "overall_status": "TERMINATED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Usher Syndrome",
        "Retinitis Pigmentosa"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "National Center for Research Resources (NCRR)",
      "sponsor_class": "NIH",
      "healthy_volunteers": true,
      "eligibility": {
        "minimum_age": "0 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "0 Years and older"
      },
      "enrollment_count": 100,
      "start_date": "1999-10",
      "completion_date": null,
      "has_results": false,
      "last_update_posted_date": "2005-06-24",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "Portland, Oregon",
      "locations": [
        {
          "city": "Portland",
          "state": "Oregon"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT00004345"
    },
    {
      "nct_id": "NCT06451757",
      "title": "KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases",
      "overall_status": "RECRUITING",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE3"
      ],
      "conditions": [
        "Mitochondrial Diseases",
        "Maternally Inherited Diabetes and Deafness (MIDD)",
        "Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like Episodes (MELAS)",
        "Mitochondrial DNA tRNALeu(UUR) m.3243A<G Mutation"
      ],
      "interventions": [
        {
          "name": "Sonlicromanol",
          "type": "DRUG"
        },
        {
          "name": "Placebo",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "Khondrion BV",
      "sponsor_class": "INDUSTRY",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "18 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "18 Years and older"
      },
      "enrollment_count": 220,
      "start_date": "2026-04-14",
      "completion_date": "2028-09",
      "has_results": false,
      "last_update_posted_date": "2026-06-29",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 3,
      "location_summary": "Boston, Massachusetts • Cleveland, Ohio • Houston, Texas",
      "locations": [
        {
          "city": "Boston",
          "state": "Massachusetts"
        },
        {
          "city": "Cleveland",
          "state": "Ohio"
        },
        {
          "city": "Houston",
          "state": "Texas"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT06451757"
    },
    {
      "nct_id": "NCT05902351",
      "title": "Natural History Study for Charcot Marie Tooth Disease",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Charcot-Marie-Tooth Disease",
        "Charcot-Marie-Tooth",
        "Charcot-Marie-Tooth Disease, Type IA",
        "Charcot-Marie-Tooth Disease Type 2A",
        "Charcot-Marie-Tooth Disease Type 2",
        "Charcot-Marie-Tooth Disease, Type 2C",
        "Charcot-Marie-Tooth Disease Type 2A2B",
        "Charcot-Marie-Tooth Disease Type 2B2",
        "Charcot-Marie-Tooth Disease Type 2A1",
        "Charcot-Marie-Tooth Disease Type 4B1",
        "Charcot-Marie-Tooth Disease, Type IB",
        "Charcot-Marie-Tooth Disease Type 2B1",
        "Charcot-Marie-Tooth Disease Type 2U (Diagnosis)",
        "Charcot-Marie-Tooth Disease Type 4A",
        "Charcot-Marie-Tooth Disease, Type 4A, Axonal Form",
        "Charcot-Marie-Tooth Disease Type 2A2A",
        "Charcot-Marie-Tooth Disease Type 2S (Disorder)",
        "Charcot-Marie-Tooth Disease and Deafness",
        "Charcot-Marie-Tooth Disease Type 4B2",
        "Charcot-Marie-Tooth Disease Type 4H",
        "Charcot-Marie-Tooth Disease Type 1F",
        "Charcot-Marie-Tooth Disease Type 4C",
        "Charcot-Marie-Tooth Disease Type 4E",
        "Charcot-Marie-Tooth Disease Type 1D",
        "Charcot-Marie-Tooth Disease Type 2Q (Diagnosis)",
        "Charcot-Marie-Tooth Disease Type 2A2",
        "Charcot-Marie-Tooth Disease Type 2N (Diagnosis)",
        "Charcot-Marie-Tooth Disease Type 2B5",
        "Charcot-Marie-Tooth Disease Type 2D",
        "Charcot-Marie-Tooth Disease Type 4D",
        "Charcot-Marie-Tooth Disease Type 2K",
        "Charcot-Marie-Tooth Disease Type 2L (Diagnosis)",
        "Charcot-Marie-Tooth Disease Type 2T",
        "Charcot-Marie-Tooth Disease Type 2I",
        "Charcot-Marie-Tooth Disease Type 2J",
        "Charcot-Marie-Tooth Disease Type 2E",
        "Charcot-Marie-Tooth Disease Type 2G",
        "Charcot-Marie-Tooth Disease Type 1C",
        "Charcot-Marie-Tooth Disease Type 2R",
        "Charcot-Marie-Tooth Disease Type 2O (Diagnosis)",
        "Charcot-Marie-Tooth Disease Type 2M",
        "Charcot-Marie-Tooth Disease Type 2P",
        "Charcot-Marie-Tooth Disease Type 2Y",
        "Charcot-Marie-Tooth Disease Type 4F (Diagnosis)",
        "Charcot-Marie-Tooth Disease Type 4B3",
        "Charcot-Marie-Tooth Disease Type 2H",
        "HNPP",
        "X-Linked Charcot-Marie-Tooth Disease",
        "Charcot Marie Tooth Disease (CMT)"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Hereditary Neuropathy Foundation",
      "sponsor_class": "OTHER_GOV",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": null,
        "sex": "ALL",
        "summary": "Not listed"
      },
      "enrollment_count": 10000,
      "start_date": "2013-11-01",
      "completion_date": "2029-12-31",
      "has_results": false,
      "last_update_posted_date": "2026-09-17",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "New York, New York",
      "locations": [
        {
          "city": "New York",
          "state": "New York"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT05902351"
    },
    {
      "nct_id": "NCT01773278",
      "title": "Cholesterol and Antioxidant Treatment in Patients With Smith-Lemli-Opitz Syndrome (SLOS)",
      "overall_status": "UNKNOWN",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "PHASE2"
      ],
      "conditions": [
        "Smith-Lemli-Opitz Syndrome",
        "Cone-Rod Dystrophy",
        "Hearing Loss"
      ],
      "interventions": [
        {
          "name": "Antioxidants",
          "type": "DRUG"
        },
        {
          "name": "Cholesterol",
          "type": "DRUG"
        }
      ],
      "intervention_types": [
        "DRUG"
      ],
      "sponsor": "University of Colorado, Denver",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": null,
        "maximum_age": "65 Years",
        "sex": "ALL",
        "summary": "Up to 65 Years"
      },
      "enrollment_count": 100,
      "start_date": "2008-12",
      "completion_date": "2025-12",
      "has_results": false,
      "last_update_posted_date": "2024-05-08",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "Aurora, Colorado",
      "locations": [
        {
          "city": "Aurora",
          "state": "Colorado"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT01773278"
    },
    {
      "nct_id": "NCT02744066",
      "title": "A Pilot Study to Evaluate Patient Tolerance and Nursing Ease-of-Use of a Novel Hearing Protection Device",
      "overall_status": "COMPLETED",
      "study_type": "INTERVENTIONAL",
      "phases": [
        "NA"
      ],
      "conditions": [
        "Hearing Impairment"
      ],
      "interventions": [
        {
          "name": "NEATCAP",
          "type": "DEVICE"
        }
      ],
      "intervention_types": [
        "DEVICE"
      ],
      "sponsor": "Michael Balsan, MD",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "12 Hours",
        "maximum_age": "2 Weeks",
        "sex": "ALL",
        "summary": "12 Hours to 2 Weeks"
      },
      "enrollment_count": 55,
      "start_date": "2017-01-31",
      "completion_date": "2017-10-05",
      "has_results": true,
      "last_update_posted_date": "2018-11-29",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "Erie, Pennsylvania",
      "locations": [
        {
          "city": "Erie",
          "state": "Pennsylvania"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02744066"
    },
    {
      "nct_id": "NCT02841553",
      "title": "Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study",
      "overall_status": "RECRUITING",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Wolfram Syndrome",
        "Diabetes Mellitus",
        "Optic Nerve Atrophy",
        "Deafness",
        "Diabetes Insipidus",
        "Ataxia"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Washington University School of Medicine",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "0 Years",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "0 Years and older"
      },
      "enrollment_count": 5000,
      "start_date": "2011-07",
      "completion_date": "2027-04",
      "has_results": false,
      "last_update_posted_date": "2025-12-23",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "St Louis, Missouri",
      "locations": [
        {
          "city": "St Louis",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT02841553"
    },
    {
      "nct_id": "NCT03951298",
      "title": "I-Tracking Neurodegeneration in Early Wolfram Syndrome",
      "overall_status": "COMPLETED",
      "study_type": "OBSERVATIONAL",
      "phases": [],
      "conditions": [
        "Wolfram Syndrome"
      ],
      "interventions": [],
      "intervention_types": [],
      "sponsor": "Washington University School of Medicine",
      "sponsor_class": "OTHER",
      "healthy_volunteers": false,
      "eligibility": {
        "minimum_age": "1 Day",
        "maximum_age": null,
        "sex": "ALL",
        "summary": "1 Day and older"
      },
      "enrollment_count": 127,
      "start_date": "2018-08-10",
      "completion_date": "2023-12-31",
      "has_results": false,
      "last_update_posted_date": "2024-08-06",
      "last_synced_at": "2026-09-18T21:02:39.095Z",
      "location_count": 1,
      "location_summary": "St Louis, Missouri",
      "locations": [
        {
          "city": "St Louis",
          "state": "Missouri"
        }
      ],
      "official_url": "https://clinicaltrials.gov/study/NCT03951298"
    }
  ]
}